DaVita has dug a narrow moat in dialysis services, operating about 35% of all dialysis clinics in the United States and some clinics globally. We believe the company’s competitive advantages in this ...
Q4 2024 revenue of $1.5 million in pharma services; full year revenue of $1.9 millionGraftAssure RUO assay launched July ...
Q4 2024 revenue of $1.5 million in pharma services; full year revenue of $1.9 millionGraftAssure RUO assay launched July ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback